Home  »  News   »  Zymeworks Inc. (ZYME) is on the roll with an avera...

Zymeworks Inc. (ZYME) is on the roll with an average volume of 1.35M in the recent 3 months

For the readers interested in the stock health of Zymeworks Inc. (ZYME). It is currently valued at $9.41. When the transactions were called off in the previous session, Stock hit the highs of $10.06, after setting-off with the price of $10.02. Company’s stock value dipped to $9.34 during the trading on the day. When the trading was stopped its value was $10.00.Recently in News on January 19, 2023, Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating Zanidatamab in HER2-Expressing Metastatic Gastroesophageal Adenocarcinoma. Results presented today at ASCO GI include first overall survival (OS) data for zanidatamab, overall confirmed objective response rate (cORR) of 79%, disease control rate (DCR) of 92%, and median progression-free survival (mPFS) of 12.5 months. You can read further details here

Zymeworks Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $10.80 on 01/19/23, with the lowest value was $7.31 for the same time period, recorded on 01/10/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Zymeworks Inc. (ZYME) full year performance was -18.53%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Zymeworks Inc. shares are logging -19.57% during the 52-week period from high price, and 128.95% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.11 and $11.70.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 632472 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Zymeworks Inc. (ZYME) recorded performance in the market was 19.72%, having the revenues showcasing 45.89% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 573.92M, as it employees total of 286 workers.

Specialists analysis on Zymeworks Inc. (ZYME)

During the last month, 8 analysts gave the Zymeworks Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.93, with a change in the price was noted +2.95. In a similar fashion, Zymeworks Inc. posted a movement of +45.67% for the period of last 100 days, recording 1,194,304 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ZYME is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Trends and Technical analysis: Zymeworks Inc. (ZYME)

Raw Stochastic average of Zymeworks Inc. in the period of last 50 days is set at 72.42%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 60.40%. In the last 20 days, the company’s Stochastic %K was 70.22% and its Stochastic %D was recorded 77.29%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 19.72%. Additionally, trading for the stock in the period of the last six months notably improved by 61.68%, alongside a downfall of -18.53% for the period of the last 12 months. The shares increased approximately by -6.27% in the 7-day charts and went down by 32.91% in the period of the last 30 days. Common stock shares were driven by 45.89% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts